Funding provided, as an equity injection through Appropriation Act (No. 1/3/5) and recognised as contributions of equity in the entity’s accounts, to prescribed NCEs to meet: 

• costs associated with replacement of minor assets (valued $10 million or less)

• costs that are eligible to be capitalised and make good costs. With the introduction of AASB16 Leases, the capital repayment component of finance leases should now be transferred to operating funding.